The ALS Association and Focused Ultrasound Foundation have partnered to support a small pilot clinical study that will leverage focused ultrasound technology as part of a new ALS treatment approach. The study will be led by Agessandro Abrahao, M.D., an assistant professor of neurology at the University of Toronto and an associate scientist at Sunnybrook Research Institute.

Signed Bill Means Safer Skies for Passengers with ALS

The ALS Association Helps Secure Easier Air Travel and Benefits for People Living With ALS

The American Academy of Neurology, The ALS Association and the American Brain Foundation have awarded the 2024 Sheila Essey Award to Eva Feldman, M.D., Ph.D., from the University of Michigan. Throughout her distinguished career, Feldman has shed light on biological processes that drive ALS development and progression, paving the way for the development of new therapies, including two first-ever human clinical trials of intraspinal stem cell implantation (injection) therapy for ALS.

Telemedicine for ALS Partnership Aims to Bridge the Gap in Care Delivery

Partnership with leading US-based ALS patient advocacy group furthers myTomorrows’ mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options

ALS Association's Top Priorities Transformed into New Laws for Hoosiers Living with ALS

We are saddened by today’s news about Relyvrio and our hearts go out to everyone in the ALS community.

On behalf of everyone living with ALS and their families, the ALS Association sent a letter this week to members of the House and Senate demonstrating our support for the passing of the ALS Better Care Act which will increase access to multidisciplinary care clinics for people living with ALS. 

$58 Million Donation Will Advance Promising ALS Research and ALS Patient Access to Care

Legislation Marks a Milestone in Ensuring Equal Access to Health Care for Individuals with Disabilities

Shoppers at Participating Stores Can Round Up for ALS – Every Cent Counts in the Fight Against ALS

The Centers for Medicare and Medicaid Services final rule prevents health insurers from using delay tactics to deny care.

Federal Government Drops Appeal Challenging D.C. Court's Decision to Make All Copays Count.

The ALS Association, the largest ALS organization in the world, and NuvoAir, the leading value-based specialty care provider for heart and lung conditions, announced their partnership to support virtual pulmonary care for people living with ALS and their caregivers.

On behalf of everyone living with ALS and their families, the ALS Association sent a letter to CVS Caremark asking company to reconsider its current policy regarding coverage of Relyvrio.

Federal Appeal Challenges D.C. Court's Directive on Copay Assistance Inclusion in Deductibles

The ALS Association is deeply concerned and disappointed about the delay in FY24 government funding. ALS research needs to be funded and increased—NOW. People living with ALS cannot wait. We call upon policymakers to prioritize ALS research and swiftly appropriate the necessary funds to support innovative research initiatives, clinical trials and the development of potential treatments.

The U.S. District Court for the District of Columbia struck down a 2021 federal rule on Monday that allowed health insurers to not count drug manufacturer copay assistance towards a beneficiary’s out-of-pocket costs. The ALS Association is part of a coalition of patient advocacy organizations supporting the effort to end “copay accumulator” policies.

On the heel of the FDA's decision on NurOwn, we are sharing our thoughts with the ALS community in our statement.